Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukemia

Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

528 public trials 91 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia trial results

Completed

Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas

NCT02900716

Conditions
B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +18 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT01671904

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • University of California San Diego Medical Center La Jolla, California, United States
  • Ingalls Hospital; Cancer Clinical Trials Harvey, Illinois, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • North Star Lodge Yakima, Washington, United States
View Trial Details
Completed

Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia

NCT02491398

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI Ancona, Italy
  • U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno Ascoli Piceno, Italy
  • S.O.C. di Medicina Interna B - Ospedale - Cardinal Massaia di Asti Asti, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy
View all 41 locations
View Trial Details
Completed

A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

NCT02264574

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Site Reference ID/Investigator# 0241 La Jolla, California, United States
  • Site Reference ID/Investigator# 0844 Fort Myers, Florida, United States
  • Site Reference ID/Investigator# 0763 West Palm Beach, Florida, United States
  • Site Reference ID/Investigator# 071 Louisville, Kentucky, United States
View all 71 locations
View Trial Details

Related conditions